抗小鼠CTLA-4抗体（克隆号9D9）引用文献
抗小鼠CTLA-4单克隆抗体（克隆号9D9）引用文献如下：
1. Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer
2. Leukemic B Cell CTLA-4 Suppresses Co-stimulation of T cells
3. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
4.Inhibition of immune checkpoints PD-1, CTLA-4, and IDO1 coordinately induces immune-mediated liver injury in mice
5.The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
6.Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
7.Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy
8.CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumors
9.TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanomas
10.Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner
11.Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
12.CTLA-4 suppresses hapten-induced contact hypersensitivity in atopic dermatitis model mice
13.ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
14.Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens
15.Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy
16.Synthetic DNA-encoded monoclonal antibody delivery of anti-CTLA-4 antibodies induces tumor shrinkage in vivo
17.Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma
18.Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer
19.Antigen receptor‐engineered Tregs inhibit CNS autoimmunity in cell therapy using nonredundant immune mechanisms in mice
20.Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer
……
Syd Labs抗小鼠CTLA-4重组抗体（克隆号9D9）：
Syd Labs 重组抗小鼠CTLA-4单克隆抗体（克隆号9D9），小鼠IgG2b Kappa，体内实验级（Grade Recombinant Anti-mouse CTLA-4 Monoclonal Antibody, Mouse IgG2b Kappa (Clone: 9D9)，货号：PA007380.m2b）是用哺乳动物细胞生产的重组抗体，可用于ELISA、流式细胞术（flow cytometry）、中和（neutralization）、功能测定（functional assays），如生物分析PK和ADA测定，以及用于研究受小鼠CTLA-4蛋白影响的生物途径的测定。
如果需要了解更多有关Syd Labs 重组抗小鼠CTLA-4抗体(克隆号9D9)信息，比如Syd Labs 抗小鼠CTLA-4抗体使用说明等资料，欢迎联系多找找获取。
特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。